查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
細胞庫外包市場 - 2017-2027年全球行業規模、佔有率、趨勢、機會和預測，按類型、按細胞類型、按階段、按公司和按地區分類
市場調查報告書
商品編碼
1289644

細胞庫外包市場 - 2017-2027年全球行業規模、佔有率、趨勢、機會和預測，按類型、按細胞類型、按階段、按公司和按地區分類

Cell Banking Outsourcing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Type, By Cell Type, By Phase, By Company, and By Region
出版日期: | 出版商: TechSci Research | 英文 112 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

在2023-2027年的預測期內，全球細胞庫外包市場預計將出現令人矚目的成長。主要因素包括慢性病的增加，父母人口意識的提高，以及老年人口的增加，這些都推動了市場的成長。細胞庫外包是一種儲存特定基因組細胞的能力，用於未來的目的。細胞庫外包可以用來製作完整的細胞系特徵，也可以幫助減少細胞系的交叉污染。支持市場成長的其他因素有：對研究和開發（R&D）活動的廣泛投資，擴大臨床試驗的數量，對幹細胞療法和基因療法的需求上升，與幹細胞應用有關的研究活動增加，對生物製品的需求增加，先進的保存技術的發展，大量的臨床試驗，以及醫療保健行業的擴張，都支持了市場的成長。此外,市場參與者擴大採用合作和收購策略,也支持市場的成長。

慢性病發病率的上升和老年人口的增加

全球範圍內慢性疾病，如糖尿病、心血管疾病和其他疾病的發生率不斷增加，正在加強市場的成長。根據世界衛生組織的數據，心血管疾病（CVDs）是全球死亡的主要原因，每年約有1790萬人死亡。幹細胞被用來治療各種慢性疾病，因為這些疾病因其不良影響而無法用傳統方法治療。因此，使用幹細胞治療作為治療劑，有助於減少治療帶來的風險或損害。由於患有這些致命疾病的人數不斷增加，對幹細胞療法和基因療法的需求正在上升，這推動了市場的成長。

越來越多的老年人口支持市場的發展

世界各地老年人口基數的增加,使幹細胞療法的需求激增,從而推動了市場的成長。根據世界衛生組織(WHO)的數據,老年人口,即60歲及以上人口的數量和比例正在增加。 2019年，60歲及以上的人的數量為10億。這個數位到2030年可能會上升到14億，到2050年可能會達到21億。

對幹細胞銀行的認知不斷提高

各個新興國家對幹細胞銀行的認知不斷提高,促進了該市場的成長。如今,人們越來越意識到幹細胞儲存對未來的好處。由於健康專家開始教育他們儲存幹細胞的意義和好處,父母和孕婦的意識也越來越強,推動了全球市場的成長。例如，在美國，捐贈者登記處包含了超過900萬的潛在捐贈者。此外，捐贈者登記處包括26.6萬個臍帶血單位，其中11.5萬個單位來自國家臍帶血庫存（NCBI），2021年將有超過4000個NCBI單位加入。

可用的定製服務

利用給定的市場數據，TechSci Research根據公司的具體需求提供定製服務。該報告有以下定製選項：

公司資訊

  • 對其他市場參與者（最多5家）的詳細分析和剖析。

目錄

第一章：產品概述

第二章：研究方法

第三章：執行摘要

第四章：COVID-19對全球細胞銀行外包市場的影響

第五章：客戶的聲音

第六章：全球細胞銀行外包市場前景

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 按類型（主細胞庫、工作細胞庫、病毒細胞庫）
    • 按細胞類型（幹細胞和/或非幹細胞）分類
    • 按階段（庫房儲存、庫房特徵和測試、庫房準備）分類
    • 按公司分類（2021年）
    • 按地區
  • 市場地圖

第7章：北美細胞銀行外包市場前景

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 按類型
    • 按細胞類型
    • 按階段分類
    • 按國家分類
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第8章：歐洲細胞銀行外包市場前景

  • 市場規模和預測
    • 按價值
  • 市場佔有率與預測
    • 按類型
    • 按細胞類型
    • 按階段分類
    • 按國家分類
  • 歐洲：國家分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙

第九章：亞太地區細胞銀行外包市場前景

  • 市場規模和預測
    • 按價值
  • 市場佔有率與預測
    • 按類型
    • 按細胞類型
    • 按階段分類
    • 按國家分類
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳大利亞

第十章：南美細胞銀行外包市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率與預測
    • 按類型
    • 按細胞類型
    • 按階段分類
    • 按國家分類
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第11章：中東和非洲細胞銀行外包市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 按類型
    • 按細胞類型
    • 按階段分類
    • 按國家分類
  • MEA: 國家分析
    • 南非細胞銀行外包
    • 沙烏地阿拉伯細胞銀行業務外包
    • 阿拉伯聯合大公國細胞銀行業務外包
    • 土耳其細胞銀行業務外包
    • 埃及細胞銀行業務外包

第十二章：市場動態

  • 驅動力
  • 挑戰

第十三章：市場趨勢與發展

第十四章：競爭格局

  • Cryo-Cell International, Inc
  • Charles River Laboratories International, Inc.
  • Goodwin Biotechnology Inc.
  • Lonza Group AG
  • SGS Life Sciences (SGS SA)
  • Global Stem Inc.
  • BSL Bioservice Scientific Laboratories GmbH
  • BioReliance Corporation

第十五章：戰略建議

簡介目錄
Product Code: 13097

The global cell banking outsourcing market is anticipated to observe impressive growth during the forecast period 2023-2027. The major factors include the increase in chronic diseases, rising awareness among the parental population, and the rise in the geriatric population, which are propelling the growth of the market. Cell banking outsourcing is an ability that stores cells of a particular genome for future purposes. Cell banking outsourcing can be used to produce complete characterizations of cell lines and can also help to reduce the cross-contamination of a cell line. The other factors supporting the market's growth are extensive investments in research and development (R&D) activities, expanding the number of clinical trials, rising demand for stem cell therapies and gene therapies, rise in research activities related to stem cell applications, increasing demand for biologic products, development of advanced preservation techniques, a large number of clinical trials, and expansion of healthcare industry are bolstering the growth of the market. Also, the growing adoption of collaboration and acquisition strategies by the market players is supporting the growth of the market.

Rising Prevalence of Chronic Diseases and Increasing Geriatric Population

The increasing occurrence of chronic diseases, such as diabetes, cardiovascular diseases, and others, across the globe is strengthening the growth of the market. According to the WHO, Cardiovascular diseases (CVDs) are the leading cause of death worldwide, taking approximately 17.9 million lives each year. Stem cells are used to treat various chronic diseases as these diseases cannot be treated with traditional methods due to their adverse effect. Therefore, the use of stem cell therapy for the treatment act as a healing agent, which helps to reduce the risk or damage caused by the treatment. Owing to the continuous rise in the number of people suffering from these fatal diseases, the demand for stem cell therapies and gene therapies is rising, which is driving the growth of the market.

Increasing Geriatric Population Supports the Market

The rise in the geriatric population base across the world is surging the demand for stem cell therapy, which is impelling the growth of the market. According to the World Health Organization (WHO) data, the number and proportion of the elderly population, meaning people with age 60 years and above in the population is increasing. In 2019, the number of people aged 60 years and above was 1 billion. This number is likely to rise to 1.4 billion by 2030 and 2.1 billion by 2050.

Growing Awareness About Stem Cell Banking

Growing awareness about stem cell banking across various emerging countries is augmenting the growth of the market. Nowadays, people are becoming more aware of the benefits of stem cell banking for future purposes. Parental as well as expectant populations are becoming more aware as health specialists are starting to educate them about the significance and advantages of storing stem cells which are fueling the growth of the market globally. For instance, in the United States, the donor registry contains above 9 million potential donors. In addition, the donor registry includes 266,000 cord blood units, of which 115,000 units are from the National Cord Blood Inventory (NCBI), with over 4000 NCBI units added in 2021.

Market Segmentation

The global cell banking outsourcing market is segmented into type, cell type, Phase, and company. Based on type, the market is divided into master cell banking, working cell banking, and viral cell banking. Based on cell type, the market is divided into stem cells and non-stem cells. Based on Phase, the market is divided into bank storage, bank characterization & testing, and bank preparation. In terms of country, the United States is expected to be a lucrative market in the forecast period due to the growing prevalence of chronic and genetic disorders in the country.

Market Players

Cryo-Cell International, Inc, Charles River Laboratories International, Inc., Goodwin Biotechnology Inc., Lonza Group AG, SGS Life Sciences (SGS SA), Global Stem Inc., BSL Bioservice Scientific Laboratories GmbH, and BioReliance Corporation are some of the leading companies operating in the market.

Report Scope

In this report, global cell banking outsourcing market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Cell Banking Outsourcing Market, By type:

  • Master Cell Banking
  • Working Cell Banking
  • Viral Cell Banking

Cell Banking Outsourcing Market, By Cell Type:

  • Stem Cell
  • Non-Stem Cell

Cord Blood Banking, By Phase:

  • Bank Storage
  • Bank Characterization & Testing
  • Bank Preparation

Cell Banking Outsourcing Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • Europe & CIS
    • Germany
    • France
    • United Kingdom
    • Spain
    • Italy
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Turkey
    • Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Cell Banking Outsourcing Market

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Impact of COVID-19 on Global Cell Banking Outsourcing Market

5. Voice of Customer

6. Global Cell Banking Outsourcing Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type (Master Cell Banking, Working Cell Banking, Viral Cell Banking)
    • 6.2.2. By Cell Type (Stem Cell v/s Non-Stem Cell)
    • 6.2.3. By Phase (Bank Storage, Bank Characterization & Testing, Bank Preparation)
    • 6.2.4. By Company (2021)
    • 6.2.5. By Region
  • 6.3. Market Map

7. North America Cell Banking Outsourcing Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Cell Type
    • 7.2.3. By Phase
    • 7.2.4. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Cell Banking Outsourcing Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Cell Type
        • 7.3.1.2.3. By Phase
    • 7.3.2. Canada Cell Banking Outsourcing Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Cell Type
        • 7.3.2.2.3. By Phase
    • 7.3.3. Mexico Cell Banking Outsourcing Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Cell Type
        • 7.3.3.2.3. By Phase

8. Europe Cell Banking Outsourcing Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Cell Type
    • 8.2.3. By Phase
    • 8.2.4. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Cell Banking Outsourcing Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Cell Type
        • 8.3.1.2.3. By Phase
    • 8.3.2. Germany Cell Banking Outsourcing Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Cell Type
        • 8.3.2.2.3. By Phase
    • 8.3.3. United Kingdom Cell Banking Outsourcing Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Cell Type
        • 8.3.3.2.3. By Phase
    • 8.3.4. Italy Cell Banking Outsourcing Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Cell Type
        • 8.3.4.2.3. By Phase
    • 8.3.5. Spain Cell Banking Outsourcing Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Cell Type
        • 8.3.5.2.3. By Phase

9. Asia-Pacific Cell Banking Outsourcing Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Cell Type
    • 9.2.3. By Phase
    • 9.2.4. By Country
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. China Cell Banking Outsourcing Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Cell Type
        • 9.3.1.2.3. By Phase
    • 9.3.2. India Cell Banking Outsourcing Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Cell Type
        • 9.3.2.2.3. By Phase
    • 9.3.3. Japan Cell Banking Outsourcing Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Cell Type
        • 9.3.3.2.3. By Phase
    • 9.3.4. South Korea Cell Banking Outsourcing Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Type
        • 9.3.4.2.2. By Cell Type
        • 9.3.4.2.3. By Phase
    • 9.3.5. Australia Cell Banking Outsourcing Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Type
        • 9.3.5.2.2. By Cell Type
        • 9.3.5.2.3. By Phase

10. South America Cell Banking Outsourcing Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Cell Type
    • 10.2.3. By Phase
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Cell Banking Outsourcing Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Cell Type
        • 10.3.1.2.3. By Phase
    • 10.3.2. Argentina Cell Banking Outsourcing Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Cell Type
        • 10.3.2.2.3. By Phase
    • 10.3.3. Colombia Cell Banking Outsourcing Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Cell Type
        • 10.3.3.2.3. By Phase

11. Middle East and Africa Cell Banking Outsourcing Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Type
    • 11.2.2. By Cell Type
    • 11.2.3. By Phase
    • 11.2.4. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Cell Banking Outsourcing Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Type
        • 11.3.1.2.2. By Cell Type
        • 11.3.1.2.3. By Phase
    • 11.3.2. Saudi Arabia Cell Banking Outsourcing Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Type
        • 11.3.2.2.2. By Cell Type
        • 11.3.2.2.3. By Phase
    • 11.3.3. UAE Cell Banking Outsourcing Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Type
        • 11.3.3.2.2. By Cell Type
        • 11.3.3.2.3. By Phase
    • 11.3.4. Turkey Cell Banking Outsourcing Market Outlook
      • 11.3.4.1. Market Size & Forecast
        • 11.3.4.1.1. By Value
      • 11.3.4.2. Market Share & Forecast
        • 11.3.4.2.1. By Type
        • 11.3.4.2.2. By Cell Type
        • 11.3.4.2.3. By Phase
    • 11.3.5. Egypt Cell Banking Outsourcing Market Outlook
      • 11.3.5.1. Market Size & Forecast
        • 11.3.5.1.1. By Value
      • 11.3.5.2. Market Share & Forecast
        • 11.3.5.2.1. By Type
        • 11.3.5.2.2. By Cell Type
        • 11.3.5.2.3. By Phase

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

  • 14.1. Cryo-Cell International, Inc
  • 14.2. Charles River Laboratories International, Inc.
  • 14.3. Goodwin Biotechnology Inc.
  • 14.4. Lonza Group AG
  • 14.5. SGS Life Sciences (SGS SA)
  • 14.6. Global Stem Inc.
  • 14.7. BSL Bioservice Scientific Laboratories GmbH
  • 14.8. BioReliance Corporation

15. Strategic Recommendations